Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/07/27 01:23:26」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

English Journal

  • Valproic acid synergistically enhances the cytotoxicity of clofarabine in pediatric acute myeloid leukemia cells.
  • Xie C, Edwards H, Lograsso SB, Buck SA, Matherly LH, Taub JW, Ge Y.SourceDepartment of Oncology, Wayne State University School of Medicine, Detroit, Michigan; Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan; The State Engineering Laboratory of AIDS Vaccine, College of Life Science, Jilin University, Changchun, P.R. China.
  • Pediatric blood & cancer.Pediatr Blood Cancer.2012 Dec 15;59(7):1245-51. doi: 10.1002/pbc.24152. Epub 2012 Apr 5.
  • BACKGROUND: Acute myeloid leukemia (AML) remains a major therapeutic challenge in pediatric oncology even with intensified cytarabine (ara-C)-based chemotherapy. Therefore, new therapies are urgently needed to improve treatment outcome of this deadly disease. In this study, we evaluated antileukemic
  • PMID 22488775
  • Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO-dependent mechanism.
  • Kelly KR, Nawrocki ST, Espitia CM, Zhang M, Yang JJ, Padmanabhan S, Ecsedy J, Giles FJ, Carew JS.SourceDivision of Hematology and Medical Oncology, Cancer Therapy and Research Center, The University of Texas Health Science Center, San Antonio, TX.
  • International journal of cancer. Journal international du cancer.Int J Cancer.2012 Dec 1;131(11):2693-703. doi: 10.1002/ijc.27579. Epub 2012 Jun 28.
  • Novel therapies are urgently needed to improve clinical outcomes for patients with acute myeloid leukemia (AML). The investigational drug alisertib (MLN8237) is a novel Aurora A kinase inhibitor being studied in multiple Phase I and II studies. We investigated the preclinical efficacy and pharmacody
  • PMID 22488249

Japanese Journal

  • 急性骨髄性白血病の化学療法 (造血器腫瘍学 : 基礎と臨床の最新研究動向) -- (骨髄系腫瘍の臨床)
  • AMLに対する高用量daunorubicin (特集 造血器腫瘍における高用量治療の評価)

Related Links

[Cytarabine] [147-94-4] | 価格や在庫、物性値などの詳細情報ページです。 ... ・川口の在庫は即日,つくばの在庫は2〜3日以内の出荷となります。 ・詳細につきましては,お手数ですが営業部までお問い合わせください。
Before receiving cytarabine injection, tell your doctor and pharmacist if you are allergic to cytarabine or any of the ingredients in cytarabine injection. Ask your pharmacist for a list of the ingredients. tell your doctor and ...

Related Pictures

CytarabineHome / CytarabineCytarabine - drug review: dosage, side arabinoside (Cytarabine) and cytarabine  chimique de l'arabinoside de cytosineCytarabine Injection

拡張検索cytarabine hydrochloride」「cytarabine ocfosphate



cytarabine,Ara-C, ara-C
シトシンアラビノシド cytosine arabinosideアラビノシルシトシン arabinosylcytosine
シタラビンオクホスファート cytarabine ocfosphate塩酸シタラビン cytarabine hydrochloride
キロサイドスタラシドサイトサール CytosarTarabine
cytarabine HC1代謝拮抗剤




  • キロサイドN注400mg/**キロサイドN注1g



arabinofuranosylcytosinecytarabinecytarabine hydrochloridecytarabine ocfosphatecytosine arabinoside









ara-Ccytarabinecytarabine hydrochloridecytosine arabinoside



cytarabine HC1

cytarabine hydrochloride」


ara-Carabinofuranosylcytosinecytarabinecytarabine ocfosphatecytosine arabinoside

cytarabine ocfosphate」

  [★] シタラビンシタラビンオクホスファート